Zeyu Shuang

875 total citations
21 papers, 625 citations indexed

About

Zeyu Shuang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Zeyu Shuang has authored 21 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Zeyu Shuang's work include Cancer Immunotherapy and Biomarkers (6 papers), Ferroptosis and cancer prognosis (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Zeyu Shuang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Ferroptosis and cancer prognosis (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Zeyu Shuang collaborates with scholars based in China and United States. Zeyu Shuang's co-authors include Xinhua Xie, Xing Li, Zhenchong Xiong, Guangzheng Deng, Xinjian Huang, Hailin Tang, Yize Mao, Jianlin Chen, Shengping Li and Guo‐He Lin and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and Medicine.

In The Last Decade

Zeyu Shuang

21 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeyu Shuang China 14 297 296 232 122 113 21 625
Satoe Fujiwara Japan 14 169 0.6× 227 0.8× 279 1.2× 89 0.7× 72 0.6× 38 677
Carl Christoph Schimanski Germany 14 223 0.8× 288 1.0× 338 1.5× 162 1.3× 186 1.6× 40 755
Alexandra Drakaki United States 12 357 1.2× 215 0.7× 430 1.9× 126 1.0× 103 0.9× 37 758
Dat Nguyen United States 10 237 0.8× 238 0.8× 414 1.8× 102 0.8× 71 0.6× 20 701
Zhanhuai Wang China 12 170 0.6× 243 0.8× 231 1.0× 59 0.5× 68 0.6× 24 501
Su Mei Cao China 6 137 0.5× 281 0.9× 173 0.7× 140 1.1× 86 0.8× 19 586
Zhanlong Shen China 15 208 0.7× 234 0.8× 251 1.1× 78 0.6× 69 0.6× 30 537
Dongmin Chang China 13 260 0.9× 184 0.6× 393 1.7× 65 0.5× 69 0.6× 25 627
Tamako Konkin United States 7 213 0.7× 233 0.8× 319 1.4× 126 1.0× 123 1.1× 8 762
Sandrina Lambrechts Belgium 18 203 0.7× 236 0.8× 280 1.2× 122 1.0× 71 0.6× 36 777

Countries citing papers authored by Zeyu Shuang

Since Specialization
Citations

This map shows the geographic impact of Zeyu Shuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyu Shuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyu Shuang more than expected).

Fields of papers citing papers by Zeyu Shuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyu Shuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyu Shuang. The network helps show where Zeyu Shuang may publish in the future.

Co-authorship network of co-authors of Zeyu Shuang

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyu Shuang. A scholar is included among the top collaborators of Zeyu Shuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyu Shuang. Zeyu Shuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yi, Jindong Xie, Guoxian Huang, et al.. (2025). Isoliquiritigenin reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in triple-negative breast cancer. Cancer Letters. 624. 217734–217734. 10 indexed citations
2.
Mao, Yize, Hui Xie, Qiuxia Yang, et al.. (2023). The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating. Cancer Immunology Immunotherapy. 72(7). 2483–2498. 13 indexed citations
3.
Xiong, Zhenchong, Lin Yang, Juan Ao, et al.. (2022). A Prognostic Model for Breast Cancer Based on Cancer Incidence-Related DNA Methylation Pattern. Frontiers in Genetics. 12. 814480–814480. 1 indexed citations
4.
Mao, Yize, Weisheng Cheng, Qiuxia Yang, et al.. (2021). The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinoma. Genomics. 114(1). 95–106. 1 indexed citations
5.
Zhong, Wenjing, et al.. (2021). Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer. Frontiers in Oncology. 11. 746058–746058. 5 indexed citations
6.
Shuang, Zeyu, Wenjing Zhong, Haoming Wu, et al.. (2021). Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC. Frontiers in Genetics. 12. 730442–730442. 3 indexed citations
7.
Sun, Hong-Wei, Wenchao Wu, Haitian Chen, et al.. (2021). Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF. Frontiers in Immunology. 11. 616367–616367. 33 indexed citations
8.
Wu, Wenchao, Hong-Wei Sun, Jing Chen, et al.. (2019). Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer. Cancer Immunology Research. 7(10). 1605–1618. 49 indexed citations
9.
Xiong, Zhenchong, Guangzheng Deng, Xinjian Huang, et al.. (2018). Score for the Survival Probability in Metastasis Breast Cancer: A Nomogram-Based Risk Assessment Model. Cancer Research and Treatment. 50(4). 1260–1269. 19 indexed citations
10.
Mao, Yize, Xin Huang, Zeyu Shuang, et al.. (2018). PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation. Cancer Medicine. 7(4). 1285–1296. 38 indexed citations
11.
Xiong, Zhenchong, Guangzheng Deng, Xinjian Huang, et al.. (2018). Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Management and Research. Volume 10. 287–295. 92 indexed citations
12.
Xiong, Zhenchong, Guangzheng Deng, Jin Wang, et al.. (2018). Could local surgery improve survival in de novo stage IV breast cancer?. BMC Cancer. 18(1). 885–885. 16 indexed citations
13.
Shuang, Zeyu, Yize Mao, Guo‐He Lin, et al.. (2018). Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity. BioMed Research International. 2018. 1–7. 12 indexed citations
14.
Xiong, Zhenchong, Lin Yang, Guangzheng Deng, et al.. (2018). Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data. Journal of Clinical Medicine. 7(6). 133–133. 26 indexed citations
15.
Wu, Jiali, Peng Liu, Hailin Tang, et al.. (2018). FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer. Current Cancer Drug Targets. 18(4). 382–389. 16 indexed citations
16.
Wu, Jiali, Zeyu Shuang, Jianfu Zhao, et al.. (2017). Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer. Biomedicine & Pharmacotherapy. 97. 1275–1281. 53 indexed citations
17.
18.
Chen, Zheng, Xiangling Wang, Ruiyan Liu, et al.. (2016). KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells. Oncotarget. 8(11). 17712–17725. 34 indexed citations
19.
Li, Xing, Hailin Tang, Jin Wang, et al.. (2016). The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer. The Breast. 32. 1–6. 77 indexed citations
20.
Lin, Guo‐He, Yongcheng Liu, Shuhong Li, et al.. (2016). Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma. Oncotarget. 7(32). 50963–50971. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoe Fujiwara Breakdown of academic impact, for papers by Carl Christoph Schimanski Breakdown of academic impact, for papers by Alexandra Drakaki Breakdown of academic impact, for papers by Dat Nguyen Breakdown of academic impact, for papers by Zhanhuai Wang Breakdown of academic impact, for papers by Su Mei Cao Breakdown of academic impact, for papers by Zhanlong Shen Breakdown of academic impact, for papers by Dongmin Chang Breakdown of academic impact, for papers by Tamako Konkin Breakdown of academic impact, for papers by Sandrina Lambrechts
Rankless by CCL
2026